Copyright
©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 812-826
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.812
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.812
Parameter | n | mean ± SD | Min | Max | Percentiles | ||
25th | 50th | 75th | |||||
CTP score | 71 | 8.94 ± 2.95 | 5.00 | 15.00 | 6.00 | 9.00 | 11.00 |
MELD score | 71 | 19.72 ± 9.86 | 6.00 | 59.00 | 11.00 | 18.00 | 25.00 |
vWF (%) | 71 | 346.18 ± 155.97 | 150 | 850 | 214.00 | 318.40 | 410.10 |
CRP (mg/L) | 71 | 21.15 ± 27.50 | 0.60 | 116.50 | 3.30 | 9.70 | 27.40 |
Ferritin (ng/mL) | 62 | 290.45 ± 354.33 | 7.20 | 1586.10 | 47.50 | 149.40 | 464.30 |
Vitamin D (ng/mL) | 46 | 17.65 ± 13.31 | 3.00 | 62.24 | 9.12 | 11.89 | 24.82 |
D-dimer (µg/mL) | 69 | 2558.4 ± 1645.1 | 99.00 | 4500.00 | 969.90 | 2420.70 | 4427.00 |
PT (s) | 71 | 20.50 ± 14.71 | 11.60 | 133.20 | 14.70 | 17.57 | 21.26 |
aPTT (s) | 70 | 43.99 ± 14.32 | 23.56 | 120.00 | 35.53 | 41.94 | 48.07 |
TT (s) | 70 | 24.10 ± 7.08 | 16.00 | 59.00 | 19.22 | 22.94 | 22.93 |
PLT (109/L) | 71 | 105.51 ± 60.52 | 18.00 | 311.00 | 62.00 | 91.00 | 127.00 |
WBC (109/L) | 71 | 6.62 ± 3.43 | 1.34 | 23.20 | 4.70 | 6.20 | 7.50 |
Bilirubin (µg/mL) | 71 | 84.73 ± 119.64 | 8.00 | 611.00 | 25.30 | 39.30 | 83.00 |
Albumin (µg/mL) | 71 | 29.68 ± 7.88 | 12.00 | 46.00 | 24.00 | 29.00 | 35.00 |
Sodium (µg/mL) | 71 | 135.65 ± 4.77 | 117.00 | 141.00 | 134.00 | 137.00 | 138.00 |
Creatinine (µg/mL) | 71 | 106.02 ± 96.15 | 41.00 | 530.00 | 61.30 | 72.00 | 105.40 |
Parameter | vWF | P value | ||||||
n | mean ± SD | Min | Max | Percentiles | ||||
25th | 50th | 75th | ||||||
CTP score | ||||||||
Class A | 18 | 258.0 ± 104.2 | 150 | 586 | 190.0 | 228.0 | 276.0 | Kruskal-Wallis H test: Chi-square (2) = 10.8177; P = 0.0045a |
Class B | 25 | 336.5 ± 122.5 | 150 | 650 | 262.0 | 341.0 | 400.0 | |
Class C | 28 | 411.5 ± 182.2 | 198 | 850 | 246.0 | 402.8 | 560.0 | |
Class А/B = Mann-Whitney U test: Z = -2.191; P = 0.028a | ||||||||
Class А/C = Mann-Whitney U test: Z = -3.028; P = 0.002a | ||||||||
Class B/C = Mann-Whitney U test: Z = -1.639; P = 0.101 | ||||||||
MELD score | ||||||||
Group 1 | 9 | 271.5 ± 106.3 | 150 | 513 | 225.0 | 257.0 | 276.0 | Kruskal-Wallis H test: Chi-square (2) = 10.3357; P = 0.0057a |
Group 2 | 33 | 301.0 ± 115.9 | 161 | 650 | 200.0 | 296.0 | 350.0 | |
Group 3 | 29 | 420.8 ± 179.7 | 150 | 850 | 258.0 | 409.0 | 548.0 | |
Group 1/2 = Mann-Whitney U test: Z = -0.690; P = 0.507 | ||||||||
Group 1/3 = Mann-Whitney U test: Z = -0.031; P = 0.029a | ||||||||
Group 2/3 = Mann-Whitney U test: Z = -2.942; P = 0.003a | ||||||||
SIRS score | ||||||||
SIRS (+) | 43 | 339.2 ± 142.0 | 150 | 680 | 200.0 | 336.5 | 409.0 | Mann-Whitney U test: Z = -0.3529; P = 0.7241 |
SIRS (-) | 28 | 356.9 ± 177.5 | 150 | 850 | 216.0 | 309.2 | 410.8 | |
Ferritin (ng/mL) | ||||||||
< 200 | 39 | 310.0 ± 140.7 | 150.0 | 650.0 | 198.0 | 262.0 | 405.0 | Kruskal-Wallis H test: Chi-square (2) = 7.1653; P = 0.0278a |
200-400 | 5 | 343.3 ± 91.2 | 253.0 | 458.9 | 258.0 | 336.5 | 410.1 | |
> 400 | 18 | 423.9 ± 171.0 | 199.7 | 850.0 | 300.0 | 400.5 | 548.0 | |
< 200/200-400 = Mann-Whitney U test: Z = -0.292; P = 0.311 | ||||||||
< 200/> 400 = Mann-Whitney U test: Z = -2.584; P = 0.010a | ||||||||
200-400/> 400 = Mann-Whitney U test: Z = -0.820; P = 0.446 | ||||||||
Vitamin D (ng/mL) | ||||||||
≤ 20 | 22 | 279.8 ± 108.9 | 150.0 | 513.0 | 199.7 | 241.0 | 344.0 | Mann-Whitney U test: Z = -1.6916; P = 0.0907 |
> 20 | 23 | 372.0 ± 179.8 | 161.0 | 850.0 | 214.0 | 385.0 | 458.9 | |
PLT (109/ L) | ||||||||
≤ 100 | 40 | 350.8 ± 171.4 | 161 | 850 | 207.2 | 312.7 | 412.1 | Mann-Whitney U test: Z = -0.02898; P = 0.9769 |
> 100 | 31 | 340.2 ± 136.0 | 150 | 598 | 239.0 | 337.0 | 405.0 | |
D-dimer (µg/mL) | ||||||||
≤ 500 | 6 | 205.2 ± 38.5 | 150 | 262 | 187.2 | 203.5 | 225.0 | Mann-Whitney U test: Z = 2.6407; P = 0.0083a |
> 500 | 63 | 355.9 ± 156.2 | 150 | 850 | 216.0 | 337.0 | 411.5 |
Parameter | Univariate Cox proportional model | Univariate logistic regression analysis | ||||||||||
3-mo | 6-mo | 1-yr | 3-mo | 6-mo | 1-yr | |||||||
Sig. | Exp (B) | Sig. | Exp (B) | Sig. | Exp (B) | Sig. | Exp (B) | Sig. | Exp (B) | Sig. | Exp (B) | |
vWF | 0.004a | 1.004 | 0.005a | 1.006 | 0.000a | 1.004 | 0.008a | 1.005 | 0.005a | 1.006 | 0.002a | 1.007 |
MELD | 0.000a | 1.144 | 0.000a | 1.157 | 0.000a | 1.116 | 0.000a | 1.191 | 0.000a | 1.157 | 0.000a | 1.176 |
CRP | 0.000a | 1.029 | 0.001a | 1,044 | 0.000a | 1.025 | 0.001a | 1.044 | 0.001a | 1.044 | 0.002a | 1.046 |
Vitamin D | 0.077 | 0.923 | 0.013a | 0.877 | 0.040a | 0.939 | 0.096 | 0.918 | 0.013a | 0.877 | 0.061 | 0.931 |
Ferritin | 0.119 | 1.001 | 0.333 | 1.001 | 0.016a | 1.001 | 0.104 | 1.001 | 0.333 | 1.001 | 0.015a | 1.003 |
aPTT | 0.000a | 1.05 | 0.068 | 1.052 | 0.000a | 1.051 | 0.059 | 1.049 | 0.068 | 1.052 | 0.067 | 1.055 |
TT | 0.258 | 1.034 | 0.588 | 1.02 | 0.426 | 1.021 | 0.292 | 1.041 | 0.588 | 1.02 | 0.529 | 1.023 |
D-dimer | 0.061 | 1 | 0.014a | 1 | 0.059 | 1 | 0.003a | 1.001 | 0.014 | 1 | 0.008 | 1 |
Dependent variable-survival in days; significant for a | Dependent variable-mortality no/yes; significant for a |
- Citation: Curakova Ristovska E, Genadieva-Dimitrova M. Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators. World J Hepatol 2022; 14(4): 812-826
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/812.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.812